56 Biggest Movers From Yesterday

Loading...
Loading...

Gainers

  • American Electric Technologies, Inc AETI shares climbed 169.93 percent to close at $1.08 on Monday after the company disclosed that its joint venture, BOMAY, received a major order for drilling rig control systems.
  • TESARO Inc TSRO gained 58.47 percent to close at $73.50 after GlaxoSmithKline plc GSK announced plans to acquire the company for $75 per share in cash.
  • Global Blood Therapeutics, Inc. GBT shares climbed 47.81 percent to close at $46.62. Global Blood announced Monday that the FDA has agreed to allow filing for its late-stage sickle cell disease, or SCD, candidate Voxelotor under an accelerated approval pathway. The company said it would submit a new drug application, or NDA, for the pipeline asset under the pathway.
  • Guardant Health, Inc. GH gained 28.58 percent to close at $45.94.
  • Lilis Energy, Inc. LLEX rose 27.67 percent to close at $2.63.
  • Vanda Pharmaceuticals Inc. VNDA shares rose 25.68 percent to close at $31.47 after the company's phase 2 study of Tradipitant met its primary endpoint and most secondary endpoints.
  • Biohaven Pharmaceutical Holding Company Ltd. BHVN rose 25.39 percent to close at $42.62 after reporting positive Phase 3 results with rimegepant zydis orally dissolving tablet for the acute treatment of migraine.
  • Apellis Pharmaceuticals, Inc. APLS gained 17.73 percent to close at $18.06 after presents updated data from ongoing APL-2 Phase 2 clinical study at the ASH 2018.
  • Laredo Petroleum, Inc. LPI climbed 17.39 percent to close at $5.13.
  • Provention Bio, Inc. PRVB gained 16.88 percent to close at $2.70.
  • Elastic N.V. ESTC climbed 14.77 percent to close at $82.00.
  • Aeterna Zentaris Inc. AEZS gained 14.5 percent to close at $3.87.
  • SI-BONE, Inc. SIBN surged 13.81 percent to close at $20.44.
  • argenx SE ARGX rose 13.49 percent to close at $109.82 after Janssen affiliate Cilag GmbH International disclosed a worldwide collaboration and license agreement with Argenx for cancer immunotherapy cusatuzumab.
  • Cenovus Energy Inc. CVE shares jumped 12.87 percent to close at $8.33.
  • SG Blocks, Inc. SGBX jumped 12.54 percent to close at $3.68 after receiving a $25 million purchase order from Phoenix Hotel & Hospitality.
  • Vapotherm, Inc. VAPO gained 12.29 percent to close at $20.65.
  • Arcus Biosciences, Inc. RCUS rose 12.17 percent to close at $12.81.
  • Osmotica Pharmaceuticals plc OSMT climbed 12.06 percent to close at $8.83.
  • Seadrill Limited SDRL shares rose 11.96 percent to close at $15.26 after dropping 7.40 percent on Friday.
  • Tribune Media Company TRCO rose 11.72 percent to close at $44.98 after Nexstar Media Group Inc NXST announced plans to acquire the company for $46.50 per share.
  • Crescent Point Energy Corp. CPG gained 11.49 percent to close at $3.30.
  • Forterra, Inc. FRTA jumped 11.43 percent to close at $5.46.
  • Advanced Micro Devices, Inc. AMD gained 11.31 percent to close at $23.71.
  • Clovis Oncology, Inc. CLVS rose 10.87 percent to close at $19.08.
  • ZAGG Inc ZAGG gained 9.95 percent to close at $11.05.
  • Wynn Resorts, Limited WYNN rose 9.5 percent to close at $119.79.
  • New Age Beverages Corporation NBEV rose 9.07 percent to close at $5.05 after the company announced plans to acquire Morinda Holdings, Inc. for $75 million in cash and $10 million in stock.
  • RadiSys Corporation RSYS rose 6.83 percent to close at $1.72 after the company reported the CFIUS clearance related to its acquisition of Reliance Industries.
  • Chart Industries, Inc. GTLS rose 6.75 percent to close at $67.85. Evercore ISI Group upgraded Chart Industries from In-Line to Outperform.
  • CASI Pharmaceuticals, Inc. CASI gained 5.31 percent to close at $4.56 after reporting China market approval of Melphalan Hydrochloride for injection.

 


Losers

  • Sienna Biopharmaceuticals, Inc. SNNA shares dipped 37.59 percent to close at $6.31 on Monday after reporting top-line results from a Phase 2b study of SNA-120.
  • Hexindai Inc. HX shares dropped 27.73 percent to close at $3.18 following Q2 results. Hexindai posted a Q2 loss of $0.36 per share on sales of $3.62 million.
  • Adial Pharmaceuticals, Inc. ADIL fell 26.3 percent to close at $2.83 on Monday after rising 37.14 percent on Friday.
  • Borqs Technologies, Inc. BRQS dropped 23.77 percent to close at $4.345 on Monday.
  • Aphria Inc. APHA declined 23.42 percent to close at $6.05 after Reuters reported that 2 research firms issued negative reports on the stock.
  • Arlo Technologies, Inc. ARLO shares declined 22.86 percent to close at $9.28. Arlo Technologies expects Q4 sales of $125 million to $130 million.
  • Tonix Pharmaceuticals Holding Corp. TNXP shares fell 22.16 percent to close at $4.04 after dropping 25.54 percent on Friday.
  • Tel-Instrument Electronics Corp. TIK fell 20.16 percent to close at $3.09 after surging 57.96 percent on Friday.
  • Realm Therapeutics Plc RLM shares tumbled 17.79 percent to close at $2.45.
  • Sphere 3D Corp. ANY dropped 17.49 percent to close at $4.34.
  • Kodiak Sciences Inc. KOD dipped 14.05 percent to close at $7.95.
  • Ocular Therapeutix, Inc. OCUL dropped 13.96 percent to close at $5.73. Cantor Fitzgerald reiterated Overweight rating on Ocular Therapeutics following the FDA approval of DEXTENZA.
  • Agios Pharmaceuticals, Inc. AGIO fell 13.66 percent to close at $56.81 after presenting updated data from the ivosidenib Phase 1 dose-escalation and expansion trial in IDH1 mutant positive patients with newly diagnosed acute myeloid leukemia ineligible for standard treatment and myelodysplastic syndrome.
  • StoneMor Partners L.P. STON dropped 13.14 percent to close at $3.04.
  • Arsanis, Inc. ASNS tumbled 13.11 percent to close at $3.38.
  • Alliqua BioMedical, Inc. ALQA shares dipped 13.04 percent to close at $2.40.
  • UTStarcom Holdings Corp. UTSI shares declined 12.61 percent to close at $3.12.
  • Trillium Therapeutics Inc. TRIL fell 12.29 percent to close at $2.64 following an update on its intratumoral TTI-621 program at the American Society of Hematology 60th Annual Meeting.
  • Xcel Brands, Inc. XELB fell 10.63 percent to close at $1.85.
  • Gamida Cell Ltd. GMDA dropped 10.38 percent to close at $13.81.
  • Aptinyx Inc. APTX fell 10 percent to close at $19.99. Aptinyx achieved its primary endpoint in the study of NYX-2925.
  • Arvinas Holding Company, LLC ARVN dropped 9.58 percent to close at $15.29.
  • Xenetic Biosciences, Inc. XBIO dipped 7.58 percent to close at $3.05.
  • Magenta Therapeutics, Inc. MGTA dropped 6.13 percent to close at $9.18.
  • bluebird bio, Inc. BLUE fell 5.2 percent to close at $116.50. bluebird bio and Celgene Corporation CELG presented initial Phase 1 data for multiple myeloma treatment candidate bb21217 at ASH 2018.
Loading...
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralInformation TechnologyIT Consulting & Other ServicesLosersMovers From YesterdayTop GainersYesterday's Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...